Abstract

We aimed to compare the effectiveness of various local anesthetic methods for controlling prostate biopsy (PBx) related pain using network meta-analysis. Literature searches were performed on PubMed/Medline, Embase, and Cochrane Library up to March 2018. Forty-seven randomized controlled trials, in which the effectiveness of PBx-related pain was investigated using a visual analogue scale after various local anesthetic methods, were included. The local anesthetic methods included intraprostatic local anesthesia (IPLA), intrarectal local anesthesia (IRLA), intravenous sedation (IVS), periprostatic nerve block (PNB), pelvic plexus block (PPB), and spinal anesthesia (SPA). Eight pairwise meta-analyses and network meta-analyses with 21 comparisons were performed. All modalities, except single use of IPLA and IRLA, were more effective than placebo. Our results demonstrate that PNB + IVS (rank 1) and SPA (rank 2) were the most effective methods for pain control. The followings are in order of PPB + IRLA, PNB + IPLA, PPB, PNB + IRLA, IVS, and PNB. In conclusion, the most effective way to alleviate PBx-related pain appears to be PNB + IVS and SPA. However, a potential increase in medical cost and additional risk of morbidities should be considered. In the current outpatient setting, PPB + IRLA, PNB + IPLA, PPB, PNB + IRLA, and PNB methods are potentially more acceptable options.

Highlights

  • The introduction of transrectal ultrasonography (TRUS)-guided prostate biopsy (PBx) in 1989 was a significant development in diagnostic methodology for detection of prostate cancer (PCa)

  • Assuming that the current PBx standard of using 10–14 biopsy cores detects prostate cancer in up to 44% of patients[52], PBx can be expected to be performed in approximately 2.5 million cases a year worldwide

  • Various types of local anesthetic methods have been proposed to reduce the discomfort and pain associated with PBx22

Read more

Summary

Introduction

The introduction of transrectal ultrasonography (TRUS)-guided prostate biopsy (PBx) in 1989 was a significant development in diagnostic methodology for detection of prostate cancer (PCa). A random sampling method is used in PBx, so 10 or more core biopsy recommended to increase the detection rate of PCa3. Severe pain can cause the patient to move during the procedure, which can increase the rate of complications and decrease the number of core that can be taken. These factors can potentially decrease accuracy of the final diagnosis[4,5]. We performed a systematic review of the published literature and network meta-analysis of the available data

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.